Market Highlights
The global Host Cell Protein Testing Market is expected to reach USD 1.2 Billion by 2030 and register a CAGR of 5.20% during the forecast period of 2022 to 2030. The growth of the global host cell protein testing market is expected to be driven by the developments in the biopharmaceutical field, and growing RD activities. Also, introduction of automated mass spectrometry for host cell protein detection is creating opportunities for the host cell protein testing market.
The growth of the global Host Cell Protein Testing Market Research is expected to be driven by key factors such as developments in the biopharmaceutical field, and growing RD activities. However, factors such as concerns pertaining to immunogenicity, and issues related to the efficiency and accuracy of the test kits are expected to restrict the market growth. In contrast, introduction of automated mass spectrometry for single cell protein detection offers lucrative opportunities for the global host cell protein testing market players.
Segment Analysis
The global Host Cell Protein Testing Market is mainly segmented into type and end user.
- On the basis of type, the host cell protein testing market has been sub-segmented into PCR-based assays, ELISA-based assays, and mass spectrometry-based assays.
- On the basis of end user, the host cell protein testing market has been segmented into contract research organizations, and biopharmaceutical companies.
Some of the key operating in the Host Cell Protein Testing Market Players are
Enzo Life Sciences, Inc. (US), Cytiva (US), Thermo Fisher Scientific Inc.(US) , Bio-Rad Laboratories, Inc. (US), Cygnus Technologies, Llc (US) , Biogenes Gmbh (Germany), Cisbio Bioassays (Europe), Charles River Laboratories International, Inc. (US), Rockland Immunochemicals, Inc.(US) and Abcam Plc (UK).
Regional Analysis
The global Host Cell Protein Testing Market Report has been segmented on the basis of region into North America, Europe, Asia-Pacific, and the Rest of the World. The North American market is further divided into the US and Canada. The European host cell protein testing market has been segmented into Germany, France, the UK, Italy, Spain, and the rest of Europe. The host cell protein testing market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World host cell protein testing market includes the Middle East, Africa, and Latin America.
North America accounted for a market size of USD 406.24 million in 2020 and is expected to exhibit a CAGR of 5.18% during the forecast period. It dominated the global host cell protein testing market due to various factors, such as developments in the biopharmaceutical industries, increasing investment in RD activities, and well-established healthcare infrastructure in the region. The US has minimal barriers and the most supportive domestic environment for the development and commercialization of pharmaceuticals. This attracts capital investments in biopharmaceutical enterprises startups. Moreover, the collaboration and partnerships of the market players are expected to bring about highly innovative, industry-leading products driving the demand for host cell protein testing across the region. Canada also has a high number of biotechnology companies. According to the Canadian Life Sciences Database, currently, the number of biotech companies in Canada is 1,042. This is fueling the growth of the host cell protein testing market in the region.
Europe has also evolved as a prominent market for host cell protein testing, with well-established RD facilities across the region, the presence of supportive regulatory systems, development of innovative and cost-effective host cell protein testing solutions by the companies. According to Statista, in 2020, USD 1,232.07 million (1,045 million euros) were spent on RD by listed biotechnology companies. The UK has a unique worldwide health and life sciences ecosystem and a strong track record of scientific breakthroughs with next-generation technologies and services. The government provides an RD platform for the companies in the market. Government initiatives and research funding are also fueling the growth of this market.
Key Findings of the Study
- The global host cell protein testing market is expected to reach USD 1,621.18 million by 2027 at a CAGR of 5.80% during the forecast period.
- The North America region accounted for the largest share of 34% in the global market in 2020, which is majorly attributed to the developments in the biopharmaceutical field, and growing RD activities.
- Based on type, the mass spectrometry-based assays segment is expected to register a CAGR of 32% during the forecast period.
- Based on end user, the biopharmaceutical companies dominated the market with a share of 48.21% in 2020.
Related Report-
About US:
Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
